Crescent Biopharma, Inc. (CBIO) News
Track canonical SquawkNews coverage tagged to CBIO, Crescent Biopharma, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 14 indexed stories across 10 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Crescent Biopharma Announces Grants of Inducement Awards
WALTHAM, Mass., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) NASDAQ:CBIO, a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for
NEWS | Sep 25, 2026, 08:21 PM UTC
L
CBIO: Major clinical data for oncology assets expected in 2027, with strong cash runway and global strategy
The company is advancing a robust oncology pipeline with a PD-1/VEGF bispecific and ADCs, supported by a global partnership and efficient clinical trial design. Major data readouts are expected in 2027, with strong finan
NEWS | Sep 14, 2026, 11:44 PM UTC
L
CBIO: Global clinical trials and major data milestones in 2027 will drive next-gen oncology combinations
A robust oncology pipeline is advancing, with global clinical trials for a PD-1/VEGF bispecific and ADCs, supported by a strategic partnership and strong financial position. Key data readouts are expected throughout 2027
NEWS | Sep 14, 2026, 11:23 PM UTC
L
CBIO: Key 2027 data from global oncology trials will drive phase III plans and registration strategies
A robust oncology pipeline is advancing, with key data from global trials of a PD-1/VEGF bispecific and ADCs expected in 2027. Strategic partnerships, efficient trial design, and a strong cash position support rapid prog
NEWS | Sep 14, 2026, 10:37 PM UTC
L
Crescent Biopharma announces grants of inducement awards
WALTHAM, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) NASDAQ:CBIO, a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for
EQUITY | Sep 09, 2026, 08:21 PM UTC
L
Crescent Biopharma management scheduled for September investor conferences
Crescent Biopharma said management is scheduled to present at September investor conferences, according to a company announcement.
EQUITY | Sep 03, 2026, 11:38 AM UTC
L
CBIO - Crescent Biopharma to Present at September Investor Conferences
CBIO - Crescent Biopharma to Present at September Investor Conferences
EQUITY | Sep 03, 2026, 11:30 AM UTC
L
Crescent Biopharma PT kept at $27 by Wedbush
Wedbush maintained its Crescent Biopharma price target at $27.00 per share.
EQUITY | Aug 27, 2026, 01:31 PM UTC
L
Crescent Biopharma Grants Inducement Awards
Crescent Biopharma grants inducement awards
EQUITY | Aug 03, 2026, 11:30 AM UTC
L
CBIO - Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
CBIO - Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
EARNINGS | Jul 30, 2026, 11:35 AM UTC
L
Deal priced today • QTTB 6.03M share Secondary, priced at $18.25, by MSCO, JEFF, Cantor, OPCO & HCW • CBIO 8.1M share Spot Secondary, priced
Deal priced today • QTTB 6.03M share Secondary, priced at $18.25, by MSCO, JEFF, Cantor, OPCO & HCW • CBIO 8.1M share Spot Secondary, priced at $14.50, by JEFF, TD Cowen, GUGG, Cantor & LifeSci Deal postponed • TP (Ticke
REGULATION | Jul 15, 2026, 12:21 PM UTC
L
Crescent Biopharma files ordinary shares offering, no amount given
Crescent Biopharma files ordinary shares offering, no amount given
EQUITY | Jul 14, 2026, 08:23 PM UTC
L
CBIO Crescent Biopharma announces proposed public offering of ordinary shares and pre-funded warrants
CBIO Crescent Biopharma announces proposed public offering of ordinary shares and pre-funded warrants
EQUITY | Jul 14, 2026, 08:01 PM UTC
L
Crescent Biopharma Files Prospectus For Offering $500M Mixed Shelf
Crescent Biopharma Files Prospectus For Offering $500M Mixed Shelf
EQUITY | Jul 01, 2026, 08:19 PM UTC